Related Experiment Video
Updated: May 11, 2026

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
Published on: November 21, 2025
Microscopic polyangiitis presenting with hemorrhagic stroke
Estíbaliz Iglesias1, Despina Eleftheriou2, Kshitij Mankad3
1Unit of Pediatric Rheumatology, Department of Pediatrics, Hospital Sant Joan de Déu, Barcelona, Spain eiglesias@hsjdbcn.org.
Abstract:
Microscopic polyangiitis associated with antineutrophil cytoplasmic antibodies directed against myeloperoxidase rarely affects the central nervous system, and this is common in the presence of other organ involvement. The authors report the case of a 12-year-old girl who presented with multiple acute parieto-occipital hematomas as the only manifestation of presumed microscopic polyangiitis. Early treatment with immunosuppression resulted in complete recovery and a favorable outcome.
Insights
Microscopic polyangiitis rarely impacts the central nervous system. A 12-year-old girl with myeloperoxidase-associated microscopic polyangiitis experienced only brain hematomas, recovering fully with immunosuppression.
Area of Science:
- Neurology
- Rheumatology
- Pediatrics
Background:
- Microscopic polyangiitis (MPA) is a rare systemic vasculitis.
- Antineutrophil cytoplasmic antibodies (ANCA) against myeloperoxidase (MPO) are associated with MPA.
- Central nervous system (CNS) involvement in MPO-ANCA-positive MPA is uncommon, especially without other organ damage.
Observation:
- A 12-year-old female presented with neurological symptoms.
- The primary clinical manifestation was multiple acute parieto-occipital hematomas.
- No other systemic organ involvement was initially detected.
Findings:
- The patient's presentation was attributed to presumed microscopic polyangiitis.
- The hematomas were the sole indicator of MPA in this case.
- Diagnosis was supported by ANCA testing, though not explicitly stated in the abstract.
Implications:
- This case highlights that CNS manifestations, such as intracranial hemorrhage, can be the sole presentation of MPA.
- Early immunosuppressive therapy can lead to favorable outcomes in pediatric MPA with CNS involvement.
- Highlights the importance of considering vasculitis in pediatric patients with unexplained neurological events.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Stroke: Introduction and Types
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction

